Healthcare / Health Information ServicesTSXV
$0.39
+0.01 (+2.63%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 13%
FCF escenarios
weak_data · normalized FCF $-1.7M · quality 35.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
11/100
F
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$21M
P/E
N/A
•EV/EBITDA
N/A
•ROE
-4726.5%
↓Gross Margin
N/A
•Debt/Equity
2.13
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+3.0%
FCF CAGR
—
FCF margin
-821.1%
FCF / Net income
0.72x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $370424.0 · net income $-4.2M · FCF $-3.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $370424.00 | $370424.00 | $664027.00 | $425632.00 | $339345.00 |
| Net Income | $-4.2M | $-4.2M | $-1.6M | $-1.0M | $-1.3M |
| EBITDA | $-4.1M | $-4.1M | $-1.5M | $-977980.00 | $-1.3M |
| EPS | -0.11 | -0.11 | -0.05 | -0.06 | -0.08 |
| Operating Margin | -1129.3% | -1129.3% | -228.0% | -236.2% | -396.1% |
| Net Margin | -1143.4% | -1143.4% | -243.2% | -242.5% | -397.7% |
| Balance Sheet | |||||
| Debt/Equity | 2.13 | 2.13 | 0.25 | 0.51 | 0.18 |
| Cash Flow | |||||
| Free Cash Flow | $-3.0M | $-3.0M | $-1.7M | $-473805.00 | $-642040.00 |
| Returns | |||||
| ROE | -4726.5% | -4726.5% | -183.9% | -694.0% | -329.9% |
| Valuation | |||||
| P/B | 171.42 | 171.42 | 5.05 | 15.75 | 4.36 |
| Growth & Yield | |||||
| Revenue Growth | -44.2% | -44.2% | 56.0% | 25.4% | — |
| EPS Growth | -120.0% | -120.0% | 16.7% | 25.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+32.2%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.05 → -0.11
Residual
+32.2%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.